169 related articles for article (PubMed ID: 33673122)
1. The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes.
Zywno H; Bzdega W; Kolakowski A; Kurzyna P; Harasim-Symbor E; Sztolsztener K; Chabowski A; Konstantynowicz-Nowicka K
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33673122
[TBL] [Abstract][Full Text] [Related]
2. Coumestrol as a new substance that may diminish lipid precursors of the inflammation in steatotic primary rat hepatocytes.
Bzdęga W; Żywno H; Kołakowski A; Kurzyna PF; Harasim-Symbor E; Chabowski A; Konstantynowicz-Nowicka K
Biochimie; 2023 Jan; 204():78-91. PubMed ID: 36084910
[TBL] [Abstract][Full Text] [Related]
3. The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Charytoniuk T; Iłowska N; Berk K; Drygalski K; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Jan; 217():1-7. PubMed ID: 30468835
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
5. Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.
Sztolsztener K; Konstantynowicz-Nowicka K; Harasim-Symbor E; Chabowski A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830360
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway.
Kołakowski A; Kurzyna PF; Żywno H; Bzdęga W; Harasim-Symbor E; Chabowski A; Konstantynowicz-Nowicka K
Molecules; 2021 Jun; 26(11):. PubMed ID: 34204938
[TBL] [Abstract][Full Text] [Related]
7. How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
Bzdęga W; Kurzyna PF; Harasim-Symbor E; Hołownia A; Chabowski A; Konstantynowicz-Nowicka K
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892425
[TBL] [Abstract][Full Text] [Related]
8. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity.
Hodun K; Sztolsztener K; Chabowski A
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684414
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.
Garbowska M; Łukaszuk B; Mikłosz A; Wróblewski I; Kurek K; Ostrowska L; Chabowski A; Żendzian-Piotrowska M; Zalewska A
J Cell Physiol; 2017 Oct; 232(10):2766-2775. PubMed ID: 28369933
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol - A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance.
Charytoniuk T; Sztolsztener K; Harasim-Symbor E; Berk K; Chabowski A; Konstantynowicz-Nowicka K
Biomed Pharmacother; 2021 Oct; 142():112057. PubMed ID: 34435590
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
14. New evidence for the role of ceramide in the development of hepatic insulin resistance.
Konstantynowicz-Nowicka K; Harasim E; Baranowski M; Chabowski A
PLoS One; 2015; 10(1):e0116858. PubMed ID: 25635851
[TBL] [Abstract][Full Text] [Related]
15. Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State.
Charytoniuk T; Harasim-Symbor E; Polak A; Drygalski K; Berk K; Chabowski A; Konstantynowicz-Nowicka K
Anticancer Agents Med Chem; 2019; 19(1):121-129. PubMed ID: 30585550
[TBL] [Abstract][Full Text] [Related]
16. Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length.
Park WJ; Park JW; Merrill AH; Storch J; Pewzner-Jung Y; Futerman AH
Biochim Biophys Acta; 2014 Dec; 1841(12):1754-66. PubMed ID: 25241943
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
18. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle.
Blachnio-Zabielska A; Baranowski M; Zabielski P; Gorski J
J Cell Physiol; 2010 Nov; 225(3):786-91. PubMed ID: 20568228
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion.
Merrill AH; Lingrell S; Wang E; Nikolova-Karakashian M; Vales TR; Vance DE
J Biol Chem; 1995 Jun; 270(23):13834-41. PubMed ID: 7775441
[TBL] [Abstract][Full Text] [Related]
20. Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells.
Babenko NA; Shakhova EG
Lipids Health Dis; 2008 Jan; 7():1. PubMed ID: 18226198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]